Labcorp Holdings annual capital expenditures (capex)
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Labcorp Holdings Capital Expenditures (CapEx) Growth & History (LH)
Labcorp Holdings's capital expenditures (capex) was $434.5M for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $434.5M | −$55.4M | −11.31% |
| 2024 | 2024-12-31 | $489.9M | $36.3M | +8.00% |
| 2023 | 2023-12-31 | $453.6M | $24.3M | +5.66% |
| 2022 | 2022-12-31 | $429.3M | $7.8M | +1.85% |
| 2021 | 2021-12-31 | $421.5M | $39.8M | +10.43% |
| 2020 | 2020-12-31 | $381.7M | −$18.5M | −4.62% |
| 2019 | 2019-12-31 | $400.2M | $20.4M | +5.37% |
| 2018 | 2018-12-31 | $379.8M | $66.9M | +21.38% |
| 2017 | 2017-12-31 | $312.9M | $34.0M | +12.19% |
| 2016 | 2016-12-31 | $278.9M | $23.1M | +9.03% |
| 2015 | 2015-12-31 | $255.8M | $52.3M | +25.70% |
| 2014 | 2014-12-31 | $203.5M | $1.3M | +0.64% |
| 2013 | 2013-12-31 | $202.2M | $28.4M | +16.34% |
| 2012 | 2012-12-31 | $173.8M | $28.1M | +19.29% |
| 2011 | 2011-12-31 | $145.7M | $19.6M | +15.54% |
| 2010 | 2010-12-31 | $126.1M | $11.4M | +9.94% |
| 2009 | 2009-12-31 | $114.7M | −$42.0M | −26.80% |
| 2008 | 2008-12-31 | $156.7M | $14.1M | +9.89% |
| 2007 | 2007-12-31 | $142.6M | — | — |
Labcorp Holdings quarterly capital expenditures (capex)
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $131.6M | $53.7M | +68.93% |
| Q1 2026 | 2026-03-31 | $121.0M | −$5.0M | −3.97% |
| Q4 2025 | 2025-12-31 | $123.9M | $11.8M | +10.53% |
| Q3 2025 | 2025-09-30 | $106.7M | −$9.1M | −7.86% |
| Q2 2025 | 2025-06-30 | $77.9M | −$50.3M | −39.24% |
| Q1 2025 | 2025-03-31 | $126.0M | −$7.8M | −5.83% |
| Q4 2024 | 2024-12-31 | $112.1M | −$55.1M | −32.95% |
| Q3 2024 | 2024-09-30 | $115.8M | $10.9M | +10.39% |
| Q2 2024 | 2024-06-30 | $128.2M | $24.9M | +24.10% |
| Q1 2024 | 2024-03-31 | $133.8M | $55.6M | +71.10% |
| Q4 2023 | 2023-12-31 | $167.2M | $68.1M | +68.72% |
| Q3 2023 | 2023-09-30 | $104.9M | $22.1M | +26.69% |
| Q2 2023 | 2023-06-30 | $103.3M | −$26.9M | −20.66% |
| Q1 2023 | 2023-03-31 | $78.2M | −$39.0M | −33.28% |
| Q4 2022 | 2022-12-31 | $99.1M | −$12.0M | −10.80% |
| Q3 2022 | 2022-09-30 | $82.8M | −$35.0M | −29.71% |
| Q2 2022 | 2022-06-30 | $130.2M | $33.0M | +33.95% |
| Q1 2022 | 2022-03-31 | $117.2M | $21.8M | +22.85% |
| Q4 2021 | 2021-12-31 | $111.1M | $11.7M | +11.77% |
| Q3 2021 | 2021-09-30 | $117.8M | $40.6M | +52.59% |
| Q2 2021 | 2021-06-30 | $97.2M | −$1.3M | −1.32% |
| Q1 2021 | 2021-03-31 | $95.4M | −$11.2M | −10.51% |
| Q4 2020 | 2020-12-31 | $99.4M | −$28.8M | −22.46% |
| Q3 2020 | 2020-09-30 | $77.2M | −$15.4M | −16.63% |
| Q2 2020 | 2020-06-30 | $98.5M | $13.3M | +15.61% |
| Q1 2020 | 2020-03-31 | $106.6M | $12.4M | +13.16% |
| Q4 2019 | 2019-12-31 | $128.2M | $6.0M | +4.91% |
| Q3 2019 | 2019-09-30 | $92.6M | −$5.3M | −5.41% |
| Q2 2019 | 2019-06-30 | $85.2M | −$2.0M | −2.29% |
| Q1 2019 | 2019-03-31 | $94.2M | $21.7M | +29.93% |
| Q4 2018 | 2018-12-31 | $122.2M | $26.1M | +27.16% |
| Q3 2018 | 2018-09-30 | $97.9M | $22.6M | +30.01% |
| Q2 2018 | 2018-06-30 | $87.2M | $17.9M | +25.83% |
| Q1 2018 | 2018-03-31 | $72.5M | $300,000 | +0.42% |
| Q4 2017 | 2017-12-31 | $96.1M | $21.8M | +29.34% |
| Q3 2017 | 2017-09-30 | $75.3M | $9.1M | +13.75% |
| Q2 2017 | 2017-06-30 | $69.3M | $2.3M | +3.43% |
| Q1 2017 | 2017-03-31 | $72.2M | $800,000 | +1.12% |
| Q4 2016 | 2016-12-31 | $74.3M | −$10.8M | −12.69% |
| Q3 2016 | 2016-09-30 | $66.2M | −$1.6M | −2.36% |
| Q2 2016 | 2016-06-30 | $67.0M | −$2.1M | −3.04% |
| Q1 2016 | 2016-03-31 | $71.4M | $37.6M | +111.24% |
| Q4 2015 | 2015-12-31 | $85.1M | $38.8M | +83.80% |
| Q3 2015 | 2015-09-30 | $67.8M | $15.2M | +28.90% |
| Q2 2015 | 2015-06-30 | $69.1M | −$29.8M | −30.13% |
| Q1 2015 | 2015-03-31 | $33.8M | −$169.7M | −83.39% |
| Q4 2014 | 2014-12-31 | $46.3M | −$13.3M | −22.32% |
| Q3 2014 | 2014-09-30 | $52.6M | $500,000 | +0.96% |
| Q2 2014 | 2014-06-30 | $98.9M | $50.1M | +102.66% |
| Q1 2014 | 2014-03-31 | $203.5M | $161.8M | +388.01% |
| Q4 2013 | 2013-12-31 | $59.6M | −$1.8M | −2.93% |
| Q3 2013 | 2013-09-30 | $52.1M | $8.0M | +18.14% |
| Q2 2013 | 2013-06-30 | $48.8M | $14.7M | +43.11% |
| Q1 2013 | 2013-03-31 | $41.7M | $7.5M | +21.93% |
| Q4 2012 | 2012-12-31 | $61.4M | $31.3M | +103.99% |
| Q3 2012 | 2012-09-30 | $44.1M | $3.7M | +9.16% |
| Q2 2012 | 2012-06-30 | $34.1M | −$11.7M | −25.55% |
| Q1 2012 | 2012-03-31 | $34.2M | $4.8M | +16.33% |
| Q4 2011 | 2011-12-31 | $30.1M | −$2.7M | −8.23% |
| Q3 2011 | 2011-09-30 | $40.4M | $6.1M | +17.78% |
| Q2 2011 | 2011-06-30 | $45.8M | $11.3M | +32.75% |
| Q1 2011 | 2011-03-31 | $29.4M | $4.9M | +20.00% |
| Q4 2010 | 2010-12-31 | $32.8M | −$4.8M | −12.77% |
| Q3 2010 | 2010-09-30 | $34.3M | $11.6M | +51.10% |
| Q2 2010 | 2010-06-30 | $34.5M | $10.8M | +45.57% |
| Q1 2010 | 2010-03-31 | $24.5M | −$6.2M | −20.20% |
| Q4 2009 | 2009-12-31 | $37.6M | — | — |
| Q3 2009 | 2009-09-30 | $22.7M | −$18.8M | −45.30% |
| Q2 2009 | 2009-06-30 | $23.7M | — | — |
| Q1 2009 | 2009-03-31 | $30.7M | — | — |
| Q3 2008 | 2008-09-30 | $41.5M | — | — |
Labcorp Holdings capital expenditures (capex) trends
Over the last five fiscal years, Labcorp Holdings's capital expenditures (capex) increased from $381.7M to $434.5M, a change of $52.8M. The latest reported quarter, Q2 2026, shows $131.6M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...